| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7c7a50d4942a781e49d2c71c6c4e4ced
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76ba102ea9c02b6633d64bf09c5b89a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b863e9acfa59d85ba0f4c97e65384d32 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-88 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 |
| filingDate |
2003-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0455ed468688e2a71621bfc66317ba2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b047489b810784fe79d01a5805a1600 |
| publicationDate |
2004-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2004021014-A2 |
| titleOfInvention |
Cox-2 mediated altered prostaglandin balance in diabetes complications |
| abstract |
The subject invention concerns novel methods for determining an individual's risk of developing diabetes-related complications. An embodiment provides determining at the onset or prior to the onset of Type I diabetes those individuals with a high risk of developing diabetes-related complications. The subject invention also concerns therapeutic methods for inhibiting and/or preventing the development of diabetes-related complications prior to or at the onset of T1D. |
| priorityDate |
2002-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |